All Episodes

February 22, 2021 30 mins
The brain is one of the most protected parts of the human body. Yet, viruses such as herpes, HIV and now SARS-CoV-2, the cause of COVID-19, have demonstrated their ability to get into this sacred space. Because the brain controls so many of our normal bodily functions, this invasion can lead to a variety of problems, known as neurological sequelae.  This week, we’re exploring what is currently known about the effect of COVID-19 on the brain and the nervous system in general. Our guest is Mark MacLean, a resident in the department of neurosurgery at Dalhousie University. He has been focused on learning more about the ways this virus get into our brains and the possible routes for treatment and possibly prevention.  While this discussion will attempt to provide you with the latest information, I’m sure you will have questions. Which is why I hope you reach out to me on Twitter, by Email, or via voice message at Speakpipe.com/SASS. Just follow the link below and send me your thoughts.   Twitter: @JATetroEmail: thegermguy@gmail.com Guest: Mark MacLeanhttps://www.researchgate.net/profile/Mark_Maclean  Mark MacLean’s paper on the potential role of microvascular pathology in the neurological manifestations of coronavirus infection https://fluidsbarrierscns.biomedcentral.com/articles/10.1186/s12987-020-00216-1  Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Advertise With Us

Popular Podcasts

24/7 News: The Latest
Therapy Gecko

Therapy Gecko

An unlicensed lizard psychologist travels the universe talking to strangers about absolutely nothing. TO CALL THE GECKO: follow me on https://www.twitch.tv/lyleforever to get a notification for when I am taking calls. I am usually live Mondays, Wednesdays, and Fridays but lately a lot of other times too. I am a gecko.

The Joe Rogan Experience

The Joe Rogan Experience

The official podcast of comedian Joe Rogan.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.